407 related articles for article (PubMed ID: 35924080)
1. Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations.
Bezzio C; Della Corte C; Vernero M; Di Luna I; Manes G; Saibeni S
Therap Adv Gastroenterol; 2022; 15():17562848221115312. PubMed ID: 35924080
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study.
Vernero M; Saibeni S; Scalvini D; Cicalini C; Chiarello L; Nardi S; Ribaldone DG; Bezzio C
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398332
[No Abstract] [Full Text] [Related]
4. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases.
Attauabi M; Zhao M; Bendtsen F; Burisch J
Inflamm Bowel Dis; 2021 May; 27(6):927-939. PubMed ID: 32628745
[TBL] [Abstract][Full Text] [Related]
6. Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases.
Ward D; Nyboe Andersen N; Gørtz S; Thorn Iversen A; Højgaard Allin K; Beaugerie L; Kirchgesner J; Jess T
Clin Gastroenterol Hepatol; 2024 Jan; 22(1):135-143.e8. PubMed ID: 37442315
[TBL] [Abstract][Full Text] [Related]
7. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
[TBL] [Abstract][Full Text] [Related]
8. Immune-mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis.
Vuyyuru SK; Kedia S; Sahu P; Ahuja V
JGH Open; 2022 Feb; 6(2):100-111. PubMed ID: 35155819
[TBL] [Abstract][Full Text] [Related]
9. Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population.
Jo UH; Lee JY; Lee H; Kim DY; Kang S; Koh SJ; Park H
J Dermatol; 2021 Apr; 48(4):431-438. PubMed ID: 33608949
[TBL] [Abstract][Full Text] [Related]
10. Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach.
García MJ; Pascual M; Del Pozo C; Díaz-González A; Castro B; Rasines L; Crespo J; Rivero M
Sci Rep; 2020 Jul; 10(1):10731. PubMed ID: 32612137
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: A population-based cross-sectional study.
Kim M; Choi KH; Hwang SW; Lee YB; Park HJ; Bae JM
J Am Acad Dermatol; 2017 Jan; 76(1):40-48. PubMed ID: 27793451
[TBL] [Abstract][Full Text] [Related]
12. Changing epidemiology of immune-mediated inflammatory diseases in immigrants: A systematic review of population-based studies.
Agrawal M; Shah S; Patel A; Pinotti R; Colombel JF; Burisch J
J Autoimmun; 2019 Dec; 105():102303. PubMed ID: 31351784
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis.
Attauabi M; Wewer MD; Bendtsen F; Seidelin JB; Burisch J
Inflamm Bowel Dis; 2022 Nov; 28(11):1756-1765. PubMed ID: 35134921
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
Bellinger DL; Lorton D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
[TBL] [Abstract][Full Text] [Related]
15. Propensity-Matched Analysis of the Risk of Age-Related Macular Degeneration with Systemic Immune-Mediated Inflammatory Disease.
Shukla P; Russell MW; Muste JC; Shaia JK; Kumar M; Nowacki AS; Hajj-Ali RA; Singh RP; Talcott KE
Ophthalmol Retina; 2024 Feb; ():. PubMed ID: 38320691
[TBL] [Abstract][Full Text] [Related]
16. Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing.
Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
Arthritis Care Res (Hoboken); 2023 Feb; 75(2):317-325. PubMed ID: 34486829
[TBL] [Abstract][Full Text] [Related]
17. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
[TBL] [Abstract][Full Text] [Related]
18. Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features.
Monteleone G; Moscardelli A; Colella A; Marafini I; Salvatori S
Autoimmun Rev; 2023 Oct; 22(10):103410. PubMed ID: 37597601
[TBL] [Abstract][Full Text] [Related]
19. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.
Principi M; Cassano N; Contaldo A; Iannone A; Losurdo G; Barone M; Mastrolonardo M; Vena GA; Ierardi E; Di Leo A
World J Gastroenterol; 2016 May; 22(20):4802-11. PubMed ID: 27239107
[TBL] [Abstract][Full Text] [Related]
20. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019.
GBD 2019 IMID Collaborators
EClinicalMedicine; 2023 Oct; 64():102193. PubMed ID: 37731935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]